
WE.FOR.YOU
About us
As a true global partner, we know how to bring products to market at competitive cost, with current deliveries spanning well over 100 countries worldwide.
Grünenthal PRO offers a unique combination of highly efficient production, with very high standards of quality and service level. We are able to adapt and segment our operation to different business models, from high volume generics, to high complexity portfolio driven business models, as well as continuous improvement frameworks for the highly competitive biopharma market.
As a family owned company, it is our long term commitment that drives sustainable partnerships with our customers.
Serialisation
All packaging sites are equipped with serialization and aggregation infrastructure to match the various national requirements.Full service in Latin America
Tour (in Spanish) of our primary manufacturing site for supply of solid, semi-solid and liquid products throughout Latin America (amongst others approved by EMA, ANVISA, INVIMA).
Grünenthal Group
Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.
Find out more

Grünenthal Report 2022/23
Our Grünenthal Report provides information about our key objectives and activities, as well as our recent business development highlights and financial performance.
Find out more